Former Lundbeck Chief Executive Anders Gersel Pedersen, M.D., Ph.D, would like to have left as managing figure in the pharmaceutical company some time before he actually did.
Today, he's a professional member of the board with posts in, among others, biotechnology company Genmab and Bavarian Nordic. For more than a decade, however, he served as executive vice president and head of research and development at Lundbeck, a position he left in the beginning of 2019.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.